Article Sidebar

Submitted
October 20, 2024
Accepted
October 20, 2024
Published
October 21, 2024
Download
PDF
Statistic
Read Counter : 557 Download : 456

Main Article Content

Abstract

Background: Hair loss, a condition with significant psychological repercussions, is influenced by various
epidemiological factors. The present study aims to investigate epidemiological factors and evaluate hair
loss in adults in Sulaimani Province.
Method: This analytical cross-sectional cohort study was conducted in 2023. Multi-clinic centers across
Sulaimani City were selected for a follow-up study involving more than 150 participants. These individuals
were divided into three groups based on their treatment type: PRP (n = 50), topical applications (n=50), and
pharmacological treatments (n = 50). Each group was monitored over a period exceeding three months,
during which clinical and demographic data were meticulously gathered.
Result: The analysis of this study identified several risk factors for hair loss with varying odds ratios:
weight (OR = 1.33, 33%), height (OR = 1.01, 1%), body mass index (BMI) (OR = 1.008, 0.8%), familial
history of hair loss (OR = 1.10, 10%), recent surgical procedures (OR = 1.03, 3%), and history of anesthesia
(OR = 1.02, 2%). The treatments showcased effectiveness in reducing hair loss and were correlated with a
significant decrease in hair loss during every session. A noticeable reduction in daily hair loss was observed
among male and female participants in all therapy groups (PRP, topical, and pharmaceutical), indicating a
positive impact on mitigating hair loss through these treatment modalities.
Conclusion: This study's findings suggest that multiple factors contribute to hair loss. Identifying,
managing, and implementing timely interventions can significantly reduce hair loss. Interventions including
PRP therapy, topical treatments, and pharmacological approaches were effectively shown to reduce hair
loss in the study participants

Keywords

Androgenetic alopecia Hair loss PRP oral supplement Topical IRAQ

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Aukerman EL, Jafferany M. The psychological consequences of androgenetic alopecia: A
  2. systematic review. J Cosmet Dermatol. 2023;22(1):89-95. https://doi.org/10.1111/jocd.14983
  3. Frith H, Jankowski GS. Psychosocial impact of androgenetic alopecia on men: A
  4. systematic review and meta-analysis. Psychol Health Med. 2024;29(4):822-42.
  5. https://doi.org/10.1080/13548506.2023.2242049
  6. Ahmed RS, Shakir SA, Mahdi AS, Noaman NG. Epidemiology of alopecia areata in
  7. Baqubah city/Diyala-Iraq. Diyala Journal of Medicine. 2023;24(2):114-9.
  8. https://doi.org/10.26505/DJM.24027260122
  9. Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. Efficacy and safety of 5%
  10. minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. Acta
  11. Dermatovenerol Alp Pannonica Adriat. 2016;25(3):41-4.
  12. https://doi.org/10.15570/actaapa.2016.12
  13. Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard
  14. Á, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19:
  15. The "Gabrin sign". J Am Acad Dermatol. 2020;83(2):680-2.
  16. https://doi.org/10.1016/j.jaad.2020.05.079
  17. Panchaprateep R, Lueangarun S. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily
  18. in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global
  19. Photographic Assessment. Dermatol Ther (Heidelb). 2020;10(6):1345-57.
  20. https://doi.org/10.1007/s13555-020-00448-x
  21. Asadi S. The role of mutations on gene AR, in androgenetic alopecia syndrome. American
  22. Journal of Molecular Biology. 2020;5:46-9. https://doi.org/10.15406/ijmboa.2020.05.00130
  23. Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a
  24. review. Endocrine. 2017;57(1):9-17. https://doi.org/10.1007/s12020-017-1280-y
  25. Tamashunas NL, Bergfeld WF. Male and female pattern hair loss: Treatable and worth
  26. treating. Cleve Clin J Med. 2021;88(3):173-82. https://doi.org/10.3949/ccjm.88a.20014
  27. Peyravian N, Deo S, Daunert S, Jimenez JJ. The Inflammatory Aspect of Male and Female
  28. Pattern Hair Loss. J Inflamm Res. 2020;13:879-81. https://doi.org/10.2147/jir.S275785
  29. Mysore V, Parthasaradhi A, Kharkar RD, Ghoshal AK, Ganjoo A, Ravichandran G, et al.
  30. Expert consensus on the management of Androgenetic Alopecia in India. Int J Trichology.
  31. ;11(3):101-6. https://doi.org/10.4103/ijt.ijt_24_19
  32. Umar S, Carter MJ. A Multimodal Hair-Loss Treatment Strategy Using a New Topical
  33. Phytoactive Formulation: A Report of Five Cases. Case Rep Dermatol Med. 2021;2021:6659943.
  34. https://doi.org/10.1155/2021/6659943
  35. Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, et
  36. al. Hormonal Effects on Hair Follicles. Int J Mol Sci. 2020;21(15).
  37. https://doi.org/10.3390/ijms21155342
  38. Lanktree MB, Haghighi A, di Bari I, Song X, Pei Y. Insights into Autosomal Dominant
  39. Polycystic Kidney Disease from Genetic Studies. Clin J Am Soc Nephrol. 2021;16(5):790-9.
  40. https://doi.org/10.2215/cjn.02320220
  41. World Medical Association Declaration of Helsinki. Ethical principles for medical
  42. research involving human subjects. Bull World Health Organ. 2001;79(4):373-4.
  43. Harries M, Macbeth AE, Holmes S, Chiu WS, Gallardo WR, Nijher M, et al. The
  44. epidemiology of alopecia areata: a population‐based cohort study in UK primary care*. British
  45. Journal of Dermatology. 2022;186(2):257-65. https://doi.org/10.1111/bjd.20628
  46. Abd El Meged MM. Patterns of hair loss at Sohag University Hospital hair clinic. Sohag
  47. Medical Journal. 2019;23(2):141-4.
  48. Morinaga H, Mohri Y, Grachtchouk M, Asakawa K, Matsumura H, Oshima M, et al.
  49. Obesity accelerates hair thinning by stem cell-centric converging mechanisms. Nature.
  50. ;595(7866):266-71. https://doi.org/10.1038/s41586-021-03624-x
  51. Łukasik A, Kozicka K, Kłosowicz A, Jaworek A, Wojas-Pelc A. The role of family history
  52. and its influence on the onset time in female pattern hair loss. Advances in Dermatology and
  53. Allergology. 2020;38:815-8. https://doi.org/10.5114/ada.2020.100745
  54. Phillips TG, Slomiany WP, Allison R. Hair Loss: Common Causes and Treatment. Am
  55. Fam Physician. 2017;96(6):371-8.
  56. Lee SH, Kang H, Lee WS. Association between Family History and Male Androgenetic
  57. Alopecia with Female Pattern Hair Loss. Ann Dermatol. 2023;35(5):348-54.
  58. https://doi.org/10.5021/ad.22.221
  59. Arias EM, Floriach N, Moreno-Arias G, Camps A, Arias S, Trüeb RM. Targeted
  60. Nutritional Supplementation for Telogen Effluvium: Multicenter Study on Efficacy of a
  61. Hydrolyzed Collagen, Vitamin-, and Mineral-Based Induction and Maintenance Treatment. Int J
  62. Trichology. 2022;14(2):49-54. https://doi.org/10.4103/ijt.ijt_57_21
  63. Di Mascio D, Sapino G, De Maria F. Telogen Effluvium as a complication of scalp
  64. reconstruction with tissue expander: a case report. Acta Biomed. 2021;92(S1):e2021431.
  65. https://doi.org/10.23750/abm.v92iS1.12066
  66. Lee H, Choi YW, Kim YC, Choi JW. Association between the first exposure to general
  67. anesthesia and alopecia areata. J Dermatol. 2023;50(5):672-8. https://doi.org/10.1111/1346-
  68. 16712
  69. Monil G, Snehal M, Veligandla KC, Rahul R, Gauri D, Bhavesh K, et al. Epidemiology
  70. and Treatment Aspects of Hair Loss in India–A Cross-Sectional, Multicentre, Database Study
  71. (HAILO). Asian Journal of Research in Dermatological Science. 2023;6(1):22-32.
  72. York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair
  73. loss. Expert Opinion on Pharmacotherapy. 2020;21(5):603-12.
  74. https://doi.org/10.1080/14656566.2020.1721463
  75. Villani A, Fabbrocini G, Ocampo-Candiani J, Ruggiero A, Ocampo-Garza SS. Review of
  76. oral minoxidil as treatment of hair disorders: in search of the perfect dose. Journal of the European
  77. Academy of Dermatology and Venereology. 2021;35(7):1485-92.
  78. https://doi.org/10.1111/jdv.17216
  79. Minta A, Park C, Rose L, Trovato S, Dulmage B. Retrospective review of oral and topical
  80. minoxidil for cancer treatment-induced hair loss. Archives of Dermatological Research.
  81. ;315(9):2613-5. https://doi.org/10.1007/s00403-023-02660-z
  82. Gressenberger P, Pregartner G, Gary T, Wolf P, Kopera D. Platelet-rich Plasma for
  83. Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study. Acta Derm
  84. Venereol. 2020;100(15):adv00247. https://doi.org/10.2340/00015555-3609
  85. Meyers A, Jin A, Kwiecien GJ, Gatherwright J, Khetarpal S, Zins JE. Platelet-Rich Plasma
  86. for Treatment of Hair Loss Improves Patient-Reported Quality of Life. Aesthetic Plastic Surgery.
  87. ;47(4):1528-34. https://doi.org/10.1007/s00266-022-03224-8
  88. Shapiro J, Ho A, Sukhdeo K, Yin L, Lo Sicco K. Evaluation of platelet-rich plasma as
  89. a treatment for androgenetic alopecia: A randomized controlled trial. Journal of the American
  90. Academy of Dermatology. 2020;83(5):1298-303. https://doi.org/10.1016/j.jaad.2020.07.006

Similar Articles

You may also start an advanced similarity search for this article.